ANOSCA: Correlating the Measure of Retinal Vascular Density Through Angio-OCT With Calcium Score

Sponsor
Centre Hospitalier Universitaire de Besancon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05624255
Collaborator
(none)
100
1
18

Study Details

Study Description

Brief Summary

Recent case-control studies have proven that the retinal vascularization mirrors the cardiac vascularization: more the coronary network is altered, more the density of retinal vessels is reduced. No studies have yet been realised in primary prevention. This study aims to demonstrate a link between the density of the retinal vascularization and the calcium score, which is currently the gold standard for the classification of cardiovascular risk in primary prevention. Thus, a simple image of the retinal vascularization could predict the cardiovascular risk of a patient. OCT angiography would become a major aid in the classification of cardiovascular risk in asymptomatic patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Ophthalmologic consultation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Correlating the Measure of Retinal Vascular Density Through Angio-OCT With Calcium Score
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: ophthalmology consultation

Patients eligible to calcium score will be offered an ophthalmologic consultation including Angio-Optical Coherence Tomography [OCT]

Other: Ophthalmologic consultation
Complete ophthalmologic examination including angio-OCT

Outcome Measures

Primary Outcome Measures

  1. Correlation between retinal vascular density and calcium score [Day 1]

    Comparison between values of calcium score and presence of vascular abnormalities in retina. Calcium is scored as follows: Coronary Artery Calcium [CAC] = 0 : very low risk CAC = [1-100[ : low risk CAC = [100-400[ : moderate risque CAC = [400-1000[ : high risk CAC = > 1000 : very high risk

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients eligible for a calcium score as part of their standard treatment and volunteers for an ophthalmologic consultation
Exclusion Criteria:
  • Pregnant women

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Besancon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Besancon
ClinicalTrials.gov Identifier:
NCT05624255
Other Study ID Numbers:
  • 2022/701
First Posted:
Nov 22, 2022
Last Update Posted:
Nov 25, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 25, 2022